Cross-fund · 5 holders
NAMS
NEWAMSTERDAM PHARMA COMPANY
CUSIP N62509109
5
Tracked holders
$69.9M
Aggregate value
2,166,884
Shares
5
Active funds
Funds holding NAMS
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $28.4M | — | +36,837 | +4.3% |
| Citadel | Multi-Strategy | Q1 2026 | $24.6M | — | +17,517 | +2.3% |
| Millennium | Multi-Strategy | Q1 2026 | $9.7M | — | +49,252 | +19.3% |
| Vanguard | Institutional | Q4 2025 | $6.1M | — | +490 | +0.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $1.2M | — | +36,400 | NEW |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.